• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢多态性与癌症易感性。

Metabolic polymorphisms and cancer susceptibility.

作者信息

Smith G, Stanley L A, Sim E, Strange R C, Wolf C R

机构信息

Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee.

出版信息

Cancer Surv. 1995;25:27-65.

PMID:8718512
Abstract

The vast majority of cancers arise as a consequence of exposure to environmental agents that are toxic or mutagenic. In response to this, all higher organisms have evolved complex mechanisms by which they can protect themselves from environmental challenge. In many cases, this involves an adaptive response in which the levels of expression of enzymes active in the metabolism and detoxification of the foreign chemical are induced. The best characterized of these enzyme systems are the cytochrome P450s, the GSTs and the NATs. An unfortunate consequence of many of these reactions, however, is the creation of a toxic or mutagenic reaction product from chemicals that require metabolic activation before realizing their full carcinogenic potential. Altered expression of one or more of these drug metabolizing enzymes can therefore be predicted to have profound toxicological consequences. Genetic polymorphisms with well defined associated phenotypes have now been characterized in P450, GST and NAT genes. Indeed, many of these polymorphisms have been associated with decreased or increased metabolism of many tumour promoters and chemical carcinogens and hence offer protection against or increased susceptibility to many distinct tumour types.

摘要

绝大多数癌症是由于接触有毒或致突变的环境因子而引发的。对此,所有高等生物都进化出了复杂的机制来保护自身免受环境挑战。在许多情况下,这涉及一种适应性反应,即诱导参与外源化学物质代谢和解毒的酶的表达水平。这些酶系统中研究得最清楚的是细胞色素P450、谷胱甘肽S-转移酶(GST)和N-乙酰转移酶(NAT)。然而,许多这些反应的一个不幸后果是,一些化学物质在充分发挥其致癌潜力之前需要代谢激活,而这些反应会产生有毒或致突变的反应产物。因此,可以预测这些药物代谢酶中一种或多种的表达改变会产生深远的毒理学后果。现已在细胞色素P450、GST和NAT基因中鉴定出具有明确相关表型的基因多态性。事实上,许多这些多态性与许多肿瘤启动子和化学致癌物的代谢减少或增加有关,因此对许多不同类型的肿瘤提供保护或增加易感性。

相似文献

1
Metabolic polymorphisms and cancer susceptibility.代谢多态性与癌症易感性。
Cancer Surv. 1995;25:27-65.
2
[Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].[治疗药物和外源性物质诱导的疗效和毒性的个体差异与外源性物质代谢酶的基因多态性的关系]
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 1998(116):69-81.
3
Environmental and chemical carcinogenesis.环境与化学致癌作用
Semin Cancer Biol. 2004 Dec;14(6):473-86. doi: 10.1016/j.semcancer.2004.06.010.
4
Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals.细胞色素P450表达的个体差异及其与化学物质肾毒性和致癌作用的关联。
IARC Sci Publ. 1991(115):281-7.
5
A nomenclature system for metabolic gene polymorphisms.代谢基因多态性的命名系统。
IARC Sci Publ. 1999(148):5-12.
6
Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.人类药物代谢酶多态性:对毒性风险和癌症的影响。
DNA Cell Biol. 1996 Apr;15(4):273-80. doi: 10.1089/dna.1996.15.273.
7
Review of studies of selected metabolic polymorphisms and cancer.特定代谢多态性与癌症的研究综述。
IARC Sci Publ. 1999(148):323-93.
8
Metabolism of xenobiotics and chemical carcinogenesis.外源性物质的代谢与化学致癌作用
IARC Sci Publ. 1999(148):13-22.
9
Human glutathione S-transferases.人类谷胱甘肽S-转移酶
Semin Liver Dis. 1998;18(4):345-58. doi: 10.1055/s-2007-1007169.
10
Genetic basis of toxic reactions to drugs and chemicals.药物和化学物质毒性反应的遗传基础。
Toxicol Lett. 2006 Mar 15;162(1):16-28. doi: 10.1016/j.toxlet.2005.10.015. Epub 2005 Nov 28.

引用本文的文献

1
Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the :c.1528C>T South African Founder Variant.携带:c.1528C>T南非始祖变异的林奇综合征同质性队列中基因多态性对癌症诊断年龄的影响。
Biomedicines. 2024 Sep 27;12(10):2201. doi: 10.3390/biomedicines12102201.
2
Do Polymorphisms of the TERT, GSTM1, and GSTT1 Genes Increase Laryngeal Cancer Susceptibility in Smokers of Romanian Descent?TERT、GSTM1 和 GSTT1 基因多态性是否会增加罗马尼亚裔吸烟者患喉癌的易感性?
Medicina (Kaunas). 2022 Aug 16;58(8):1106. doi: 10.3390/medicina58081106.
3
Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
N-乙酰基转移酶2(NAT2)、细胞色素P450 1A1(CYP1A1)和细胞色素P450 1A2(CYP1A2)基因多态性、杂环胺与前列腺癌风险之间的关联:日本的一项病例对照研究
Environ Health Prev Med. 2017 Oct 24;22(1):72. doi: 10.1186/s12199-017-0681-0.
4
Genetics and epigenetics of varicocele pathophysiology: an overview.精索静脉曲张病理生理学的遗传学与表观遗传学:综述
J Assist Reprod Genet. 2017 Jul;34(7):839-847. doi: 10.1007/s10815-017-0931-5. Epub 2017 May 18.
5
Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis.N-乙酰转移酶2与膀胱癌的风险:一项荟萃分析。
Onco Targets Ther. 2015 Dec 11;8:3715-20. doi: 10.2147/OTT.S82927. eCollection 2015.
6
No association of GSTM1 null polymorphism with endometriosis in women from central and southern Iran.伊朗中部和南部女性中谷胱甘肽S-转移酶M1基因无效多态性与子宫内膜异位症无关联。
Iran J Reprod Med. 2012 Jan;10(1):23-8.
7
The associations between two vital GSTs genetic polymorphisms and lung cancer risk in the Chinese population: evidence from 71 studies.中国人群中两种重要的谷胱甘肽S-转移酶基因多态性与肺癌风险的关联:来自71项研究的证据。
PLoS One. 2014 Jul 18;9(7):e102372. doi: 10.1371/journal.pone.0102372. eCollection 2014.
8
Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility.外源性物质和雌激素代谢途径(CYP1A1和CYP1B1)的基因变异与胆囊癌易感性的关联。
Tumour Biol. 2014 Jun;35(6):5431-9. doi: 10.1007/s13277-014-1708-4. Epub 2014 Feb 18.
9
Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.突尼斯患者中CYP1A1和CYP2D6基因多态性与头颈癌的关联
Mol Biol Rep. 2014;41(4):2591-600. doi: 10.1007/s11033-014-3117-6. Epub 2014 Jan 22.
10
The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China.GSTP1 105Val 等位基因增加乳腺癌风险和侵袭性,但增强了华北地区对环磷酰胺化疗的反应。
PLoS One. 2013 Jun 24;8(6):e67589. doi: 10.1371/journal.pone.0067589. Print 2013.